Description: Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor's office, surgery, mobile clinics, hospital bedsides, and workplaces and airports. The company was incorporated in 2020 and is based in Lund, Sweden.
Home Page: diagonalbio.com
The Spark
Lund,
223 81
Sweden
Phone:
46 7 03 05 24 88
Officers
| Name | Title |
|---|---|
| Ms. Karin Wehlin MBA | Chief Executive Officer |
| Mr. Kushagr Punyani | Tech Advisor, Founding Partner & Director |
| Mr. Andreas Nyberg | Founder & Chief Scientific Officer |
| Mr. Johan Kallstrand | Founding Partner |
| Ms. Fata Mrsic | Chief Financial Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.294 |
| Price-to-Sales TTM: | 0.7233 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |